A pilot investigation on breast cancer patients undergoing traditional and hypofractionated radiation therapy suggested that MMPs (specifically MMP-3 and MMP-9) and TIMP4 could be valuable prognostic and predictive biomarkers. Here, MMP9 is linked to breast carcinoma.